STEVEN I SHERMAN to Carcinoembryonic Antigen
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Carcinoembryonic Antigen.
Connection Strength
0.445
-
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy. Ann Oncol. 2013 Sep; 24(9):2256-61.
Score: 0.419
-
Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol. 2013 Oct 10; 31(29):3639-46.
Score: 0.027